Latest It Consulting News

The Foreign Investment Review Board has formally objected to Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma, casting serious doubt on the deal’s future and prompting Mayne to explore alternative paths.

Iron Road Ltd's recent surface sampling at the Irria Prospect reveals promising concentrations of valuable heavy minerals, including titanium and zircon, paving the way for a targeted drilling campaign starting December 2025.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

State Gas Limited has independently certified a maiden 2P gas reserve of 30.2 petajoules at its Rolleston West Project, establishing a solid foundation for a pipeline-connected gas development aimed at the east coast market.

Ausmon Resources reports promising rare earth element assay results from its Jabuk Prospect in South Australia, revealing concentrations up to 1,452 ppm TREO. The company plans an extensive grid drilling program to further define this emerging mineralisation.

Emu NL announces the departure of CEO Adrian Griffin and the appointment of Non-Executive Director Peter Swiridiuk as interim CEO, signaling a leadership transition at the mining explorer.

Aspermont Limited has appointed John Stark and David Straface as interim directors, reinforcing its board with seasoned insiders during a pivotal growth phase focused on data and intelligence services for global resource sectors.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its women’s and men’s health products Dyspro™ and Libbo™.

American Uranium Limited has initiated hydrogeological testing alongside Phase 1 drilling at its Lo Herma ISR uranium project, aiming to expand its resource and validate aquifer conditions critical for in-situ recovery mining.

Tivan Limited has made significant progress on its Speewah Fluorite Project in Western Australia, completing a major drilling phase and advancing its Feasibility Study, now scheduled for completion in February 2026. The project aims to produce acidgrade fluorspar for global markets, supported by strong joint venture partnerships and strategic financing.

BCAL Diagnostics is preparing to launch its Avantect® pancreatic and ovarian cancer blood tests in Australia by January 2026, following key regulatory approvals and promising clinical data. The company also broadens the reach of its BREASTESTplus™ breast cancer test, targeting a larger segment of women with dense breast tissue.

EVE Health Group has partnered with telehealth provider hubMed to deliver a national patient support program, enhancing care continuity for users of its Dyspro and Libbo therapies.